As discussed above, we found that the IL6 antibody exerted a suppressive effect on glioma cells in vitro by antagonizing hypoxia-induced autophagy and promoting apoptosis, suggesting that tocilizumab may inhibit glioma growth in vivo. This evidence concerns the gene IL6 and central nervous system cancer.